Terveystalo issues EUR 100 million sustainability-linked notes
Terveystalo Plc Stock Exchange Release 25 May 2023 at 18:45 EEST
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Terveystalo Plc (“Terveystalo”) issues senior unsecured sustainability-linked notes in the aggregate principal amount of EUR 100 million (the “Notes”). The Notes will mature on 1 June 2028 and carry initially a fixed annual interest of 5.375 per cent. The issue date for the Notes will be 1 June 2023.
"We are proud to announce the successful issuance of EUR 100 million sustainability-linked notes, showcasing our commitment to social responsibility and sustainable finance. By integrating ESG criteria into our capital structure, we create lasting value for stakeholders while addressing pressing challenges. This milestone reaffirms our dedication to sustainability and propels us toward a more responsible and resilient future", Terveystalo CFO Juuso Pajunen comments.
Terveystalo will submit an application for the Notes to be admitted to trading on the official list of Nasdaq Helsinki Ltd. The net proceeds of the issue of the Notes will be used for refinancing of the existing indebtedness of Terveystalo or its subsidiaries and for general corporate purposes of the Terveystalo group.
OP Corporate Bank plc and Skandinaviska Enskilda Banken AB (publ) act as joint lead managers for the issue of the Notes and joint sustainability-linked framework advisers.
For further information, please contact:
Juuso Pajunen, CFO
Tel. +358 40 584 9722
Kati Kaksonen, Vice President, Investor Relations, Sustainability & Communications
Tel. +358 10 345 2034
Distribution:
Nasdaq Helsinki Ltd
Principal media
www.terveystalo.com
Terveystalo in brief
Terveystalo is the largest private health care service provider in Finland in terms of revenue and network. Terveystalo is also a leading occupational health provider in Finland. We offer a wide variety of primary health care, specialized care, and well-being services for corporate and private customers and the public sector. Terveystalo’ s digital services are available 24/7, regardless of time and place. Health and well-being services are also provided by Terveystalo’ s over 370 clinics across Finland. In Sweden, we offer occupational health services at 155 clinics. Terveystalo is listed on the Helsinki Stock Exchange and has a predominantly Finnish ownership.
In 2022, Terveystalo had approximately 1.3 million individual customers in Finland and the number of customer appointments was approximately 8.5 million, with more than a quarter of these taking place via remote channels. Terveystalo employs over 16,800 healthcare and well-being professionals. www.terveystalo.com
Important information
The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or such other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. No actions have been taken to register or qualify the Notes, or otherwise to permit a public offering of the Notes.
This communication does not constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any state of the United States, and the Notes may not be offered, sold, pledged or otherwise transferred, directly or indirectly, within the United States or to, or for the account or benefit of, any U.S. person (as such terms are defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This communication does not constitute an offer of Notes to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the Notes. Consequently, this communication is addressed to and directed only at persons in the United Kingdom who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) are other persons to whom the Prospectus and offering of the Notes may be otherwise lawfully communicated (all such persons together being referred to as “relevant persons”). This release is directed only at relevant persons and any person who is not a relevant person must not act or rely on this release or any of its contents.